20230810 coronavirus omicron

COVID-19 vaccination and boosting during pregnancy benefits pregnant people and newborns

The researchers found that pregnant women who received the COVID-19 vaccines generated antibodies against specific types of SARS-CoV-2. These antibodies crossed the placenta and were also found in the cord blood of vaccinated participants. This likely conferred some protection in the newborns against infection immediately after birth—a critical time when they are vulnerable to severe COVID-19 disease but are too young to be vaccinated.

Continue reading
Screenshot 2023 03 01 at 8.18.14 AM

Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments—FDA warns

The FDA is particularly concerned that these deceptive and misleading products might cause people to delay, skip or stop appropriate medical treatment for COVID-19, leading to serious and life-threatening harm. It’s likely that the products do not do what they claim, and the ingredients in them could cause adverse effects (bad reactions) and could interact and potentially interfere with medications to treat many underlying medical conditions.

Continue reading
Electron micrograph of SARS-CoV-2, the coronavirus responsible for COVID-19

Three in five long COVID patients have organ damage a year after infection

From this first set of scans, we found 331 participants (62%) had organ damage. Impairment of the liver, pancreas, heart and kidneys were most common (affecting 29%, 20%, 19% and 15% of participants respectively). These 331 participants were followed up six months later with a further MRI scan.

We found that three in five of the original study participants (59%) had impairment in at least one organ a year after infection, while just over one in four (27%) had impairment in two or more organs. So, for the vast majority of participants who had organ damage at six months, it was sustained until at least 12 months.

While in some cases participants with organ damage were no longer experiencing symptoms, organ impairment was associated with a higher likelihood of persistent symptoms and reduced function at 12 months.

Continue reading